06/11/2026
Metropolis Labs on Business Today TV
Q2 FY27 was a quarter of all-round progress for Metropolis.
Revenue rose 16% year-on-year to ₹497 crore, and profit after tax climbed 43% to ₹75 crore. EBITDA increased 24% to ₹135 crore, with margin improving 180 basis points to 27.2%. Behind these numbers are more people choosing us. Patient volumes grew 10% and test volumes 11%, with every business adding to the momentum: B2C, B2B, preventive wellness and specialty diagnostics.
Our Managing Director, Mr. Surendran Chemmenkotil, joined Business Today TV to talk about what drove the quarter. He covered how we are deepening our presence in Tier II and III cities, scaling specialty and preventive testing, and widening our network so quality diagnostics reach more families across India. He also shared what lies ahead for the business.
At Metropolis, every report carries a responsibility, and every milestone reflects the trust patients and doctors place in us.
Metropolis Healthcare reported a strong Q2 FY27 performance, with revenue rising 16% year-on-year to ₹497 crore and profit after tax increasing 43% to ₹75 crore. EBITDA grew 24% to ₹135 crore, while EBITDA margin expanded 180 basis points to 27.2%. Patient and test volumes grew 10% and 11%, re...